Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > Starpharma Projects Receive ARC Grants

July 6th, 2004

Starpharma Projects Receive ARC Grants

Abstract:
Melbourne-based nanotechnology company Starpharma Holdings Limited has received peer endorsement of its dendrimer technology with the funding of two separate projects by the Australian Research Council. The projects will advance pharmaceutical applications of SPL’s dendrimer technology by clarifying how dendrimers interact with drug targets, pathogens and other biological structures. The studies will receive a total of $440,000 over three years under the ARC scheme of competitive grants. (PDF)

Source:
Starpharma

Bookmark:

Related News Press

Investments/IPO's/Splits

Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013

Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013

Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013

Nanometrics Announces Upcoming Investor Events May 14th, 2013